GLP Watchdog

Embody vs RxSpan MD

Neither Embody nor RxSpan MD has an FDA warning letter on record. On compounded tirzepatide injection, Embody costs $2,400 less a year at standing rates: $129 a month against $329 a month at RxSpan MD. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Embody / RxSpan MD

Embody logo

Embody

9.3/10

RxSpan MD logo

RxSpan MD

7.9/10

FDA warning letters
None on record
None on record
Pharmacy
Lowest standing price
$79/moCompounded semaglutide injection
$249/moCompounded semaglutide injection
States
All 50 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Embody
Visit RxSpan MD

Both Embody and RxSpan MD are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Embody 9.3, RxSpan MD 7.9). How we are paid

What the record shows

  1. 01

    Neither Embody nor RxSpan MD has an FDA warning letter on record.

  2. 02

    Embody names four pharmacies. RxSpan MD names four pharmacies.

  3. 03

    On compounded tirzepatide injection, Embody costs $2,400 less a year at standing rates: $129 a month against $329 a month at RxSpan MD. It is one of two products the two sell at comparable terms.

  4. 04

    Only Embody lists a price for compounded oral tirzepatide. Only RxSpan MD lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Embody

RxSpan MD

Compounded semaglutide injection

$79/moLower

$948 a year

$249/mo

$2,988 a year

Compounded tirzepatide injection

$129/moLower

$1,548 a year

$329/mo

$3,948 a year

Brand-name semaglutide pen
Not sold or not priced

$1,299/mo

$15,588 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,069/mo

$12,828 a year

Compounded oral tirzepatide

$329/mo

$3,948 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the one-month plan; 3-, 6- and 12-month plans are prepaid
None
Refunds
No refunds once paid; a partial refund only after a medical disqualification
Not stated
Early-exit fee
None stated
None stated

Read off each seller’s own pages. Embody: October 30, 2026. RxSpan MD: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Embody

9.3/10
  • $2,040 a year less on compounded semaglutide injection
  • $2,400 a year less on compounded tirzepatide injection
  • Sells compounded oral tirzepatide, which RxSpan MD does not price
Visit Embody

The case for RxSpan MD

7.9/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Embody does not price
Visit RxSpan MD

Scores

Embody 9.3 · RxSpan MD 7.9 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
3.5

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

9.0A
vs
B
10.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
8.5

The score is the same formula for every seller. Payment does not enter it. Method

Embody vs RxSpan MD: questions

Neither Embody nor RxSpan MD has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Embody names four pharmacies. RxSpan MD names four pharmacies. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Embody, by $2,040 a year at standing rates. Embody: $79 a month, about $948 a year. RxSpan MD: $249 a month, about $2,988 a year.
Embody states you can cancel at any time; refunds: no refunds once paid; a partial refund only after a medical disqualification. RxSpan MD states you can cancel at any time.
Both Embody and RxSpan MD are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Embody 9.3, RxSpan MD 7.9).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks